AuthorCommitMessageCommit dateIssues
Emma WhitedEmma Whited
e4485835b54Edited cder_sir_wp007 description
Emma WhitedEmma Whited
c0c623a77e8Edited cder_sir_wp007 description
Emma WhitedEmma Whited
f296150b675Edited cder_sir_wp007 description
WhitedWhited
bb76391ba1cSentinel Query: cder_sir_wp007_public_v01
Aaron MadowAaron Madow
ac2414b7662Added cder_sir_wp009
Lizzie BeersLizzie Beers
59dc8084b12added cder_mpl2p_wp039, cder_mpl2p_wp044, and cder_mpl2p_wp047
Emma WhitedEmma Whited
f0de93eb50bAdded Trends in Healthcare Utilization During the COVID-19 Pandemic: A Propensity Score Matched and Stratified Analysis and Trends in Healthcare Utilization During the COVID-19 Pandemic: A Follow Up Propensity Score Matched and Stratified AnalysisCOVID-19
Lizzie BeersLizzie Beers
e398c3af94aadded Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched AnalysisCOVID-19
Lizzie BeersLizzie Beers
c18f58bfb4bAdded Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched AnalysisCOVID-19
Lizzie BeersLizzie Beers
cd76ab78330added Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched AnalysisCOVID-19
Whitney ChlonWhitney Chlon
73405bbfda1Added Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis and Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Obesity: A Descriptive AnalysisGLP-1
Emma WhitedEmma Whited
ef4bb477d97Added Serious Infection Following Ustekinumab Use in Patients with Crohn’s Disease: An Inverse Probability of Treatment Weighting Analysis
Lizzie BeersLizzie Beers
55057bbd3c0Added Interstitial Lung Disease (ILD) Rates in Patients with Inflammatory Bowel Disease (IBD) and Following IBD Advanced Therapy: A Descriptive Analysis
Lizzie BeersLizzie Beers
74bd440a81fAdded Interstitial Lung Disease (ILD) in Patients with Inflammatory Bowel Disease (IBD) and Following Vedolizumab or Natalizumab Initiation: A Descriptive Analysis
Emma WhitedEmma Whited
13545dab23bAdded Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Emma WhitedEmma Whited
51e68e63dd8Added Hydrochlorothiazide Use Following Labeling Update to Include the Risk of Non-Melanoma Skin Cancer: An Interrupted Time Series Analysis
Lizzie BeersLizzie Beers
1765e67a95dAdded Intentional Self-Harm Following Montelukast Use in Patients with Asthma: An Updated Analysis Using ICD-10-CM CodingICD-10
Lizzie BeersLizzie Beers
5a24c312d0dAdded Outcome Monitoring Following Dupilumab Use: A Signal Identification Analysis
Lizzie BeersLizzie Beers
804cab111ceAdded Outcome Monitoring Following Baloxavir Use: A Signal Identification Analysis
Emma WhitedEmma Whited
7746ff956baupdated cder_mpl2p_wp023 title
Emma WhitedEmma Whited
ed6dec4e481added cder_mpl2p_wp043
Emma WhitedEmma Whited
8307da78fdcadded cder_mpl2r_wp018
Lizzie BeersLizzie Beers
5ae7df5bf64added cder_sir_wp004
Whitney ChlonWhitney Chlon
dc2fde8b66dAdded Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: An Updated Propensity Score Analysis
Lizzie BeersLizzie Beers
61a200827cfAdded cder_mpl2r_wp019
Whitney ChlonWhitney Chlon
dc100c0a709readme.md edited online with Bitbucket
Whitney ChlonWhitney Chlon
8b5979d5b90readme.md edited online with Bitbucket
Whitney ChlonWhitney Chlon
0300eeb0a1aAdded Race and Ethnicity Associations Among Patients Hospitalized with COVID-19: A Covariate Stratified AnalysisCOVID-19
Emma WhitedEmma Whited
a6cfabd103areadme.md edited online with Bitbucket
Lizzie BeersLizzie Beers
05128291a77added cder_mpl1p_wp072 and cder_mpl1p_wp063
Lizzie BeersLizzie Beers
016bb41f4efadded cder_mpl1r_wp228 and cder_mpl1r_wp240
Ryan SchoepleinRyan Schoeplein
2741f44dc58Removed duplicate "cder_mpl2r_wp012" entry to Table of Contents
Ryan SchoepleinRyan Schoeplein
e560969bf40Outcome Monitoring Following Zarxio Use: A Signal Identification Analysis
Ryan SchoepleinRyan Schoeplein
443efd98363Added Outcome Monitoring Following Ozempic Use in Patients with Type 2 Diabetes: A Signal Identification Analysis
Lizzie BeersLizzie Beers
9a8a8204821corrected a typo in the title of cder_mpl2p_wp011
Lizzie BeersLizzie Beers
e03bbf3d036moved cder_mpl2p_wp011 to the top of the table of contents
Lizzie BeersLizzie Beers
129ddf27207Added cder_mpl2p_wp024
Lizzie BeersLizzie Beers
be16cef05f3Added Seizures following Gadolinium-Based Contrast Agents Exposure: A Self-Controlled Risk Interval Analysis
Ryan SchoepleinJ SteinmanRyan Schoeplein
d939d9519a2Added Characterizing Pregnant Women With and Without Evidence of Heart Failure and Non-Pregnant Women With Heart Failure: A Propensity Score Matched Analysis
Whitney ChlonJ SteinmanWhitney Chlon
c3913861e27Added Thromboembolic Stroke, Major Extracranial Bleeding, Gastrointestinal Bleeding, and Intracranial Hemorrhage following Direct Oral Anticoagulant Use: An Inverse Probability of Treatment Weighting Analysis
Lizzie BeersJ SteinmanLizzie Beers
d48dde5829dAdded "cder_mpl2p_wp020 Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis (an update to cder_mpl2p_wp012)" to the table of contents
Lizzie BeersJ SteinmanLizzie Beers
56c2b32933bFixed the table of contents formatting
Lizzie BeersJ SteinmanLizzie Beers
df07b5a3209Added "cder_mpl2p_wp012 Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis" to table of contents
Meredith CantwellJ SteinmanMeredith Cantwell
02586dc6b7aAdded Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis
Regan WoodnuttJ SteinmanRegan Woodnutt
23ac88c31c0Added Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis, Parts 1 and 2.
Ryan SchoepleinJ SteinmanRyan Schoeplein
bdca9a754ceAdded Cutaneous Small-Vessel Vasculitis following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis
Ryan SchoepleinJ SteinmanRyan Schoeplein
905a102a3d3Added Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis
Meredith CantwellJ SteinmanMeredith Cantwell
7e9e75b8fbdAdded A New Propensity Score Matched Analysis Tool for Pregnancy: Replicating A Study of Oral Clefts following Topiramate Use during the First Trimester of Pregnancy
Meredith CantwellJ SteinmanMeredith Cantwell
b5552a93e58Added Factors Related to the Assignment of Sodium Glucose Cotransporter-2 Inhibitors (SGLT-2i) versus Dipeptidyl Peptidase-4 Inhibitors (DPP-4i)
Ryan SchoepleinJ SteinmanRyan Schoeplein
deb59ef0aefAdded "Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis"

Everything looks good. We'll let you know here if there's anything you should know about.

Add shortcut